ArticleBritish journal of haematology2026

Real-world outcomes of idecabtagene vicleucel in relapsed/refractory multiple myeloma: A single-centre experience.

Taku Kikuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.